Vertex Pharmaceuticals Incorporated - VRTX (NASDAQ-GS)

0.90 (0.58%)
Quotes delayed 15 mins. Currently May 20, 2018 7:20:51 PM
By signing up, you can buy this stock for just $4.95 or purchase it within a Motif
Vertex Pharmaceuticals researches and develops small molecule drugs for the treatment of liver diseases and HIV/AIDS

Key Financials

Day Range:155.33 - 157.52
52 Week Range:115.10 - 178.25
Market Cap:40.07B
P/E Ratio:180.70
Div Yield:--
Previous close
No Chart Available
Purchase VRTX in a Motif
A motif is an intelligently weighted basket of up to 30 stocks and ETFs built around themes and investing styles.
On our platform, you can buy shares of VRTX not only as a single stock, but also as part of a motif.
Community Motifs with VRTX
Disease Buster 2
Disease Buster 2 9.5% 1 YR RTN
S&P Profit Screen 05L
S&P Profit Screen 05L 10.6% 1 YR RTN
Biotech Growth
Biotech Growth 16.1% 1 YR RTN
View all community motifs with VRTX
What Others Think About VRTX
Jeff Cory
I have s family member with CF. We have applauded $VRTX for all they have done for #CF . I trust they will do the ri……
JD Alexander
Cure for CF may be coming out of $SGMO freezer soon. $VRTX $CRSP follies. Learn from $GILD $PFE $SNY & go w/ best GE
$674.90 Million in Sales Expected for Vertex Pharmaceuticals $VRTX This Quarter
Dakota Financial
$0.71 Earnings Per Share Expected for Vertex Pharmaceuticals $VRTX This Quarter
Registrar Journal
$0.71 Earnings Per Share Expected for Vertex Pharmaceuticals $VRTX This Quarter
Dispatch Tribunal
Vertex Pharmaceuticals $VRTX Expected to Post Earnings of $0.71 Per Share
JD Alexander
$SGMO Non-viral Delivery of ZFN mRNA Enables Highly Efficient In Vivo Gene Editing of Mult Gene Targets - lung $VRTX
RT @Jdalexander64 : @Jdalexander64 $VRTX hope you’re watching $SGMO threat to CF franchise & it’s not $GLPG
Related Companies Within The Biotechnology Sector
Amgen Inc. - 176.30
Biogen Inc. - 280.40
Shire plc - 169.61